glp-1 obesity drug news today october 16 2025 New Daily Weight Loss Pill Aims to Take on Ozempic GLP-1 RA Weight Loss Drugs

This NMA results indicate when there is no particular need to lose weight, liraglutide can be chosen for treatment

The first pathway requires a BMI greater than 27 combined with either prediabetes or established cardiovascular disease

Congressional Budget Office, which suggested the cost of the drugs could still exceed the savings from treating obesity and its attendant health conditions

When the body experiences substantial caloric deficit and metabolic changes, it may prioritize essential functions over non-essential processes like hair growth

Key Findings Breast cancer incidence was lower in women who had used GLP-1 drugs than in women who had not

While the inflammation-reducing and fibrosis-attenuating effects of glucagon agonism are less well-characterized, the reductions in hepatic inflammation parameters and fibrosis observed in preclinical models likely reflect secondary effects consequent to improved steatosis, rather than direct anti-inflammatory actions [21]